Blog
Elderly patients better off taking placebo in new Risperdal study
Feb. 9, 2017 – San Diego, CA — For elderly patients in palliative care, treating symptoms of delirium with the antipsychotic Risperdal may make some...
FDA speeds up recall process – now posts on website as soon as recall occurs
Feb. 8, 2017 — San Diego, CA — U.S. consumers will now know when a medical device is recalled sooner than they had in the...
What do lemons have to say about breast cancer? Apparently, a lot!
Feb. 7, 2017 — San Diego, CA — The nonprofit group Worldwide Breast Cancer is using an unlikely source to make it easier for women to detect...
Farxiga plaintiffs denied ‘class-wide’ consolidation with Invokana request new MDL
Feb. 6, 2017 – San Diego, CA — People injured by the type II diabetes medication Farxiga may see their cases consolidated after all. One...
Will J&J try to settle the next Risperdal lawsuit before it heads to trial? [UPDATE]
Feb. 22, 2017 — Johnson & Johnson settled the case one week before it went to trial. Read the story on our blog: J&J continues settlement...
Hernia mesh study shows risk of serious complications can outweigh benefits
Feb. 2, 2017 – San Diego, CA — The benefits of using surgical mesh to repair hernias may be outweighed by the risks of mesh...
Alternative therapy to prevent chemo hair loss slapped with FDA warning; agency said device marketed without approval
Feb. 1, 2017 – San Diego, CA — The maker of a popular cold cap therapy for chemotherapy patients is under fire from the U.S....
Nexplanon ‘Almost Ruined My Life’: How one girl figured out her birth control was causing her unusual anxiety and depression
When one college student realized her life was headed in a downward spiral, she looked to an unlikely culprit and found answers. ...
Risperdal, Xarelto lawsuits responsible for massive caseloads in Philly court
Jan. 30, 2017 – San Diego, CA — Lawsuits have been piling up against Johnson & Johnson and its subsidiaries in recent years. From baby...
Independent advisory committees under scrutiny by FDA, critics
Jan. 27, 2017 – San Diego, CA — In response to criticisms, the U.S. Food and Drug Administration (FDA) is looking into how it selects...
Warning: Undefined variable $additional_loop in /www/nationalinjury_896/public/wp-content/themes/national-injury/page-news.php on line 43
Warning: Attempt to read property "max_num_pages" on null in /www/nationalinjury_896/public/wp-content/themes/national-injury/page-news.php on line 43
